摘要
Lysine-MCC-DM1, MCC-DM1 and DM1 are potential catabolites of trastuzumab emtansine (T-DM1). A convenient liquid chromatography-tandem mass spectrometry (LC–MS/MS) method was developed and validated to detect these catabolites simultaneously in in vitro investigations for the first time. Protein precipitation was utilized to prepare the samples. Chromatographic separation was achieved on a Phenomenex Kinetex C18 column (100 × 2.1 mm, 2.6 μm) with mobile-phase gradient elution. The calibration curves of each analyte ranging from 1 to 100 nM showed good linearity (r2 > 0.995). The method was validated successfully and applied to the intracellular catabolism and regulation of T-DM1.
| 源语言 | 英语 |
|---|---|
| 页(从-至) | 170-177 |
| 页数 | 8 |
| 期刊 | Journal of Pharmaceutical and Biomedical Analysis |
| 卷 | 137 |
| DOI | |
| 出版状态 | 已出版 - 15 4月 2017 |
| 已对外发布 | 是 |
学术指纹
探究 'LC–MS/MS method for the simultaneous determination of Lys-MCC-DM1, MCC-DM1 and DM1 as potential intracellular catabolites of the antibody-drug conjugate trastuzumab emtansine (T-DM1)' 的科研主题。它们共同构成独一无二的学术指纹。引用此
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver